Literature DB >> 4966318

Kinin formation and kininogen depletion in rats after intravenous injection of ellagic acid.

K M Gautvik, H E Rugstad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4966318      PMCID： PMC1557345          DOI： 10.1111/j.1476-5381.1967.tb00406.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  11 in total

1.  ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

Authors:  O D RATNOFF; J D CRUM
Journal:  J Lab Clin Med       Date:  1964-03

2.  STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID.

Authors:  R E BOTTI; O D RATNOFF
Journal:  J Lab Clin Med       Date:  1964-09

3.  KINIRASE ACTIVITY OF HUMAN SALIVA.

Authors:  E AMUNDSEN; K NUSTAD
Journal:  Nature       Date:  1964-03-21       Impact factor: 49.962

4.  Role of Hageman factor in the activation of vasodilator activity in human plasma.

Authors:  M E WEBSTER; O D ATNOFF
Journal:  Nature       Date:  1961-10-14       Impact factor: 49.962

5.  Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation.

Authors:  J MARGOLIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

6.  The mode of action of Hageman factor in the release of plasma kinin.

Authors:  J MARGOLIS
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

7.  Formation of plasma kinins by plasmin.

Authors:  G P LEWIS
Journal:  J Physiol       Date:  1958-02-17       Impact factor: 5.182

8.  Purification of a kinin-inactivating enzyme from cultures of Pseudomonas aeruginosa.

Authors:  H E Rugstad
Journal:  Br J Pharmacol Chemother       Date:  1967-05

9.  Characterization of a plasma kinin-inactivating enzyme produced by Pseudomonas aeruginosa.

Authors:  H E Rugstad
Journal:  Br J Pharmacol Chemother       Date:  1967-06

10.  Substrates for plasma kinin-forming enzymes in rat and guinea-pig plasma.

Authors:  S Jacobsen
Journal:  Br J Pharmacol Chemother       Date:  1966-10
View more
  14 in total

1.  Failure of ellagic acid to affect platelet aggregation in normal and in factor XII deficient plasma.

Authors:  A Girolami; L Virgolini; R Peruffo; L de Marco
Journal:  Blut       Date:  1975-08

2.  Arachidonic acid-induced paw oedema in the rat [proceedings].

Authors:  J Cottney; A J Lewis; D J Nelson
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

3.  Lack of inhibition of ellagic acid induced hypercoagulable state and lack of thrombosis in the dog after PAMBA administration.

Authors:  A Girolami; A Brunetti; G Cella; S Pedrazzoli
Journal:  Blut       Date:  1977-05

4.  Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

5.  [The influence of ellagic acid on the oncolytic effect of clostridium M55 (author's transl)].

Authors:  J R Möse; G Fischer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

6.  [Kininogen content of serum and plasma following tissue injury in rats].

Authors:  H P Zach; E Werle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Some pharmacodynamic properties of cellulose sulphate, a kininogen-depleting agent in the rat.

Authors:  A M Rothschild
Journal:  Br J Pharmacol Chemother       Date:  1968-07

8.  Lowering of kininogen in rat blood by adrenaline and its inhibition by sympatholytic agents, heparin and aspirin.

Authors:  A Castania; A M Rothschild
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

9.  Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat.

Authors:  J Damas; A Adam
Journal:  Experientia       Date:  1980-05-15

10.  Mechanism of the congestion of lymph nodes induced by ellagic acid in rats.

Authors:  J Damas; G Remacle-Volon; A Adam
Journal:  Agents Actions       Date:  1987-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.